IL17A and Brain atrophy: A relevant study revealed that plasma levels of peripheral inflammatory markers, such as BAFF/TNFSF13B, IL-4, IL-6, IL-17A, and TNF-α, exhibited associations with patterns of brain atrophy, brain hypometabolism, and clinical measures of disease severity and functional status in bvFTD [65].